Read Today’s Newspaper
☰ Mobile Logo

JFDA authorises emergency use of Pfizer's COVID-19 oral Paxlovid pill

By JT | 19:36 February 3, 2022 |
Share Story

AMMAN — The Jordan Food and Drug Administration (JFDA) has granted an emergency use authorisation (EUA) for Pfizer's COVID-19 oral Paxlovid pill.

JFDA Director-General Nizar Mhiedat on Thursday said that EUA was declared after the administration’s technical committees evaluated the safety of the medication and favourable results were shown, the Jordan News Agency, Petra, reported.

Used to treat mild-to-moderate COVID infection in adults above 18 years, Paxlovid comprises 100 mg ritonavir and 150 mg nirmatrelvir.

Paxlovid is available by prescription only, and it is not recommended during pregnancy, and breastfeeding should be interrupted during treatment.

.col-lg-12.second .opinion-widget{border-top:1px solid #D0D0D0;} #widget_1623 .opinions-title {font-size:32px;}

{{articles_filter_1623_widget?.title}}

{{ articles_filter_1623[0]?.section_name }}

{{ articles_filter_1623[0]?.title }}
Opinion Author
{{ articles_filter_1623[1]?.author_name }}

{{ articles_filter_1623[1]?.title }}
.epaper-separator{ height: 1px; width: 100%; background-color: #D0D0D0; margin: 15px 0; }

Today’s Paper

Today's Paper
.related-articles .layout-ratio{padding-bottom:55%;}
Related Articles
.alert-success { color :#A3656F ; } .alert-danger { color : red ; } .footer { font-family:Myriad Pro,Arial; }
The Jordan Times Logo

The Jordan Times is an independent English-language daily published by the Jordan Press Foundation since October 26, 1975. The Jordan Press Foundation is a shareholding company listed on the Amman Stock Exchange.

Join Our Newsletters

Sign up by email to receive news.

Camera Icon Read Today’s Newspaper

Copyright © 2025 The Jordan Times. All Rights Reserved.

document.addEventListener('DOMContentLoaded', function () { function validateEmail(email) { return /^[^\s@]+@[^\s@]+\.[^\s@]+$/.test(email); } function showModal(message,type) { const messageContainer = document.getElementById("messageContainerFooter"); messageContainer.textContent = message; messageContainer.className = `alert alert-${type} mt-3`; // Bootstrap alert styling messageContainer.classList.remove("d-none"); // Hide message after 5 seconds setTimeout(() => { messageContainer.classList.add("d-none"); }, 5000); } document.getElementById("emailFormFooter").addEventListener("submit", function(event) { event.preventDefault(); const emailInput = document.getElementById("emailFooter"); const email = emailInput.value.trim(); if (!validateEmail(email)) { showModal('Invalid email format','danger'); return; } const url = `/subscribeNewsletter?email=${encodeURIComponent(email)}`; fetch(url, { method: "GET", headers: { "Accept": "application/json" } }) .then(response => { if (!response.ok) { showModal("Error submitting email. Try again.",'danger'); } return response.json(); }) .then(data => { showModal(data.message,'success'); }) .catch(error => { showModal("Error submitting email. Try again.",'danger'); }); }); });